MLCL — Molecule Holdings Balance Sheet
0.000.00%
Last trade - 00:00
Consumer DefensivesHighly SpeculativeMicro Cap
2018 October 31st | 2019 October 31st | 2020 October 31st | 2021 October 31st | 2022 October 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.019 | 0.005 | 1.14 | 1.2 | 0.084 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.008 | 0.009 | 0.103 | 0.391 | 0.283 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 0.028 | 0.014 | 1.53 | 2.71 | 1.28 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 3.73 | 0 | 3.92 | 3.25 | 2.63 |
Long Term Investments | |||||
Total Assets | 3.76 | 0.978 | 5.45 | 5.96 | 3.91 |
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.334 | 0.473 | 1.14 | 4.35 | 7.52 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.334 | 0.473 | 2.01 | 5.32 | 7.61 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 3.43 | 0.505 | 3.44 | 0.638 | -3.69 |
Total Liabilities & Shareholders' Equity | 3.76 | 0.978 | 5.45 | 5.96 | 3.91 |
Total Common Shares Outstanding |